LONDON, July 31 (Reuters) – AstraZeneca is accelerating its push into cancer immunotherapy, with plans to test a key experimental drug in new tumour types.

from Reuters: Mergers News http://ift.tt/1rLpwp9
via IFTTT

Publicités